Identification of the m6A RNA Methylation Regulators WTAP as a Novel Prognostic Biomarker and Genomic Alterations in Cutaneous Melanoma
Background: The purpose of our research was to establish a gene signature and determine the prognostic value of m6A methylation regulators in cutaneous melanoma and WTAP as a protective gene in cutaneous melanoma prognosis, we also evaluated gene mutations in cutaneous melanoma.Methods: We downloade...
Main Authors: | Zi-Yi Feng, Ting Wang, Xin Su, Shu Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.665222/full |
Similar Items
-
Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer
by: Jiangchu Lei, et al.
Published: (2022-09-01) -
The Emerging, Multifaceted Role of WTAP in Cancer and Cancer Therapeutics
by: Guomin Ju, et al.
Published: (2023-06-01) -
WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
by: Yuan Xuesong, et al.
Published: (2023-10-01) -
Prognostic biomarker CCR6 and its correlation with immune infiltration in cutaneous melanoma
by: Yeltai Nurzat, et al.
Published: (2023-04-01) -
WTAP Gene Variants Confer Hepatoblastoma Susceptibility: A Seven-Center Case-Control Study
by: Zhen-Jian Zhuo, et al.
Published: (2020-09-01)